RAPT

FLX Bio is an anti-cancer biopharmaceutical startup focused on the discovery, development, and commercialization of novel drugs in tumor immunology. The company leverages its unique insights in cancer biology and immunology to discover and develop new oral small-molecule cancer immune modulators that activate anti-cancer immune responses to eliminate cancer cells.